News Related to Association for Accessible Medicines

Related coverage linked through entity extraction aliases.

Drugmakers Challenge Trump's International Drug Pricing Models

Mar 04, 2026

Major pharmaceutical and biotech companies are urging the Trump administration to withdraw two Medicare pricing proposals that would align U.S. drug prices with international benchmarks, arguing the mandatory models exceed government authority and threaten innovation.

FDA Chief Makary Pushes OTC Drug Expansion, Addresses GLP-1 Compounding and China Competition

Feb 18, 2026

FDA Commissioner Marty Makary outlined plans to expand over-the-counter drug access, crack down on unlawful GLP-1 compounding, and address the U.S. falling behind China in early-stage drug development.